The long term results of surgery for hepatocelluar carcinoma are not satisfactory, because the high incidence of intrahepatic tumor recurrence, with a 5-year acturial recurrence rate of 75% to 100%. The risk factors for postoperative recurrence such as venous invasion, presence of satellite nodules, large tumor size, advanced TNM stages are the best-established. For the management of postoperative recurrence, studies largely focused on the recurrence in the remnant liver. The therapeutic modalities commonly used for surgical resection, TACE, percutaneous ethanol injection (PEIT), and systemic chemotherapy. We report a case of recurrent hepatocellular carcinoma after curative resection, successfully treated by TACE, TACI, and systemic chemotherapy with long term survival.